このページは機械翻訳されています。他のページは英語で表示される場合があります。 View in English

81 H−15 N NMRプローブによってGタンパク質結合受容体を通して追跡された活性化ダイナミクス

  • 0Biozentrum, University of Basel, Basel, Switzerland.
Clinical Neuroscience (new York, N.y.) +

|

|

まとめ

この要約は機械生成です。

研究者は,β1 アドレナゲン受容体 (β1AR) の動態を研究するために,パラマグネティック NMR を使用した. リガンドとナノボディが受容体の形状と信号伝達メカニズムをどのように変化させるかを明らかにした.

科学分野

  • 生物化学
  • 分子生物学
  • 構造生物学

背景

  • Gタンパク質結合受容体 (GPCR) のシグナル伝達には,動的な形状の変化が含まれます.
  • これらのダイナミクスを研究する以前の方法は,解像度と範囲が限られていた.

研究 の 目的

  • 新しいNMR技術を用いてβ1アドレナリン受容体 (β1AR) の構造動態を調査する.
  • β1ARにおける信号伝達とアロステリック変調のメカニズムを解明する.

主な方法

  • β1ARにおける81の1H-15N NMR相関を追跡するために,パラマグネティックなNMR法を使用した.
  • 様々なオーステリックリガンドとGタンパク質を模倣するナノボディで環境条件下での受容体の行動を研究した.

主要な成果

  • β1AR内の保存されたxWIPF3モチーフのダイナミクスを詳細に示した.
  • プロリン残留物によって分離された固体と柔軟な形状結合の領域を特定した.
  • トランスデューサー (ナノボディ) の結合時に細胞内受容体の可塑性を観察した.

結論

  • この研究は,β1ARの構成動態とアロステル調節に関する高解像度な洞察を提供します.
  • この発見は,GPCRのシグナル伝達メカニズムとリガンド誘発型選択の理解を深める.

関連する概念動画

Activation and Inactivation of G Proteins 01:22

6.5K

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...

G-protein Coupled Receptors 01:21

113.9K

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.

The G-protein or guanine nucleotide-binding protein, is a large heterotrimeric complex. Its three subunits...

Amplifying Signals via Enzymatic Cascade 01:22

8.2K

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...

G Protein-coupled Receptors 01:15

11.0K

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...

Amplifying Signals via Second Messengers 01:15

6.6K

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...

Transducer Mechanism: G Protein–Coupled Receptors 01:30

1.8K

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...